Live Breaking News & Updates on Utoimmune Disease Assets

Stay updated with breaking news from Utoimmune disease assets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Glenmark Pharmaceuticals and Ichnos Sciences establish alliance for cancer drug discovery

IGI is introducing a pipeline of three oncology molecules currently undergoing clinical trials, targeting multiple myeloma, acute myeloid leukemia, and solid tumors. ....

New York , United States , Glenn Saldanha , Cyril Konto , Eli Lilly , Glenmark Pharmaceuticals Ltd , Ichnos Sciences Inc , Glenmark Pharmaceuticals , Ichnos Sciences , Ichnos Glenmark Innovation , New York City , Managing Director , Glenmark Innovation , Ichnos Sciences Inc , Ichnos Glenmark Innovation , Cancer Treatments , Small Molecule Research , Novel Biologics , Orphan Drug Designation , S Fda , Utoimmune Disease Assets , Hematological Malignancies , Solid Tumors , Ncology Molecules , Clinical Trials , Multiple Myeloma ,